These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2290290)

  • 1. [Proliferative vitreoretinopathy: new discoveries in pathophysiology and therapy].
    Wiedemann P; Weller M; Heimann K
    Klin Monbl Augenheilkd; 1990 Nov; 197(5):355-61. PubMed ID: 2290290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen gel contraction by cells associated with proliferative vitreoretinopathy.
    Guidry C; McFarland RJ; Morris R; Witherspoon CD; Hook M
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2429-35. PubMed ID: 1634340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitronectin: mediator of cell adhesion in proliferative vitreoretinopathy?].
    Weller M; Wiedemann P; Bresgen M; Heimann K
    Fortschr Ophthalmol; 1990; 87(2):221-5. PubMed ID: 1694159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages.
    Kirchhof B; Sorgente N
    Dev Ophthalmol; 1989; 16():1-53. PubMed ID: 2676632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proliferative vitreoretinopathy. Pathogenesis and possibilities for treatment with cytostatic drugs].
    Wiedemann P; Heimann K
    Klin Monbl Augenheilkd; 1986 Jun; 188(6):559-64. PubMed ID: 3761957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferative vitreoretinopathy. On the significance of protein transfer through the blood-retina barrier].
    Grisanti S; Wiedemann P; Heimann K
    Ophthalmologe; 1993 Oct; 90(5):468-71. PubMed ID: 8219633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of proliferative vitreoretinopathy.
    Wiedemann P; Weller M
    Acta Ophthalmol Suppl (1985); 1988; 189():3-15. PubMed ID: 2851252
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
    Heidenkummer HP; Kampik A
    Fortschr Ophthalmol; 1991; 88(3):219-24. PubMed ID: 1889766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro.
    Martini B
    Acta Ophthalmol Suppl (1985); 1992; (201):1-63. PubMed ID: 1322004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mononuclear phagocytes in proliferative vitreoretinopathy (PVR). A specific role of microglial cells in non-traumatic disease?
    Weller M; Esser P; Heimann K; Wiedemann P
    Eur J Ophthalmol; 1991; 1(4):161-6. PubMed ID: 1821209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes.
    Heidenkummer HP; Kampik A
    Ger J Ophthalmol; 1992; 1(3-4):170-5. PubMed ID: 1483131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative vitreoretinopathy. Ultrastructural study of 20 retroretinal membranes removed by vitreous surgery.
    Schwartz D; de la Cruz ZC; Green WR; Michels RG
    Retina; 1988; 8(4):275-81. PubMed ID: 3231920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Baudouin C; Brignole F; Fredj-Reygrobellet D; Nègre F; Bayle J; Gastaud P
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2822-9. PubMed ID: 1382045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mononuclear phagocytes and their growth factors: pacemakers of proliferative vitreoretinopathy?].
    Weller M; Heimann K; Wiedemann P
    Klin Monbl Augenheilkd; 1990 Mar; 196(3):121-7. PubMed ID: 2188039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistology of proliferative vitreoretinopathy following giant tear detachment].
    Weller M; Bresgen M; Heimann K; Wiedemann P
    Klin Monbl Augenheilkd; 1989 Nov; 195(5):323-5. PubMed ID: 2689766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M; Esser P; Heimann K; Wiedemann P
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of drug treatments for proliferative vitreoretinopathy using vitreous microtensiometry.
    Moorhead LC; Sepahban S; Armeniades CD
    Ann Ophthalmol; 1991 Sep; 23(9):349-55. PubMed ID: 1741609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture.
    Machemer R
    Invest Ophthalmol Vis Sci; 1988 Dec; 29(12):1771-83. PubMed ID: 3056866
    [No Abstract]   [Full Text] [Related]  

  • 20. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M; Esser P; Wiedemann P; Heimann K
    Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.